Regeneron Pharma (REGN) PT Raised to $716 at Credit Suisse
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $837.18 -0.44%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Credit Suisse analyst Evan Seigerman raised the price target on Regeneron Pharma (NASDAQ: REGN) to $716.00 (from $700.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Shanghai Conant Optical (2276:HK) PT Lowered to HK$81.40 at Macquarie
- Eclat Textile Co Ltd (1476:TT) PT Lowered to NT$547 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
